Higuchi John W.
SEC Form 4 insider trading activity
Higuchi John W. has filed 4 SEC Form 4 filings (5 transaction rows) across 1 company, with disclosures dating back to 2026. 4 of those filings fall inside the rolling window. Most recent filing: Oct 2, 2026.
On the most recent filing, Higuchi John W. is listed as Director at Lipocine Inc. Inside the rolling window, Higuchi John W. reported 5 open-market purchases totaling $416K in LPCN and no open-market sales. The largest disclosed transaction in the window is a purchase of 123,000 LPCN shares on Apr 6, 2026, worth $252K.
Companies traded
Other insiders at LPCN
Insider Buying
$416K
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Higuchi John W. made?
Higuchi John W. has filed 4 SEC Form 4 filings (5 transaction rows) across 1 company since 2026.
Which companies does Higuchi John W. trade?
Higuchi John W. has filed SEC Form 4 disclosures for 1 company, including LPCN.
When was Higuchi John W.'s most recent SEC Form 4 filing?
Higuchi John W.'s most recent SEC Form 4 filing on Tracefour is dated Oct 2, 2026.
What is Higuchi John W.'s total buy and sell value in the current window?
Inside the rolling retention window, Higuchi John W. bought $416K and sold $0 based on SEC Form 4 filings.
What was Higuchi John W.'s largest disclosed transaction?
The largest disclosed transaction in the current window is a purchase of 123,000 LPCN shares on 2026-04-06, worth $252K, per SEC Form 4 filings.